These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 6215538

  • 1. Distribution and percentages of non-protein bound contraceptive steroids in human serum.
    Hammond GL, Lähteenmäki PL, Lähteenmäki P, Luukkainen T.
    J Steroid Biochem; 1982 Oct; 17(4):375-80. PubMed ID: 6215538
    [Abstract] [Full Text] [Related]

  • 2. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
    Hammond GL, Langley MS, Robinson PA, Nummi S, Lund L.
    Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179
    [Abstract] [Full Text] [Related]

  • 3. Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum.
    Kuhnz W, Pfeffer M, al-Yacoub G.
    J Steroid Biochem; 1990 Feb; 35(2):313-8. PubMed ID: 2308344
    [Abstract] [Full Text] [Related]

  • 4. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration.
    Granger LR, Roy S, Mishell DR.
    Am J Obstet Gynecol; 1982 Nov 01; 144(5):578-84. PubMed ID: 6890312
    [Abstract] [Full Text] [Related]

  • 5. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM, Mills RJ.
    Ann Clin Biochem; 1981 Jul 01; 18(Pt 4):226-31. PubMed ID: 7197136
    [Abstract] [Full Text] [Related]

  • 6. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W, Assendorp R, Kloosterboer L, van Lier W, Voortman G, Qvist I.
    Am J Obstet Gynecol; 1990 Dec 01; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
    Kuhnz W, Staks T, Jütting G.
    Contraception; 1993 Dec 01; 48(6):557-75. PubMed ID: 8131397
    [Abstract] [Full Text] [Related]

  • 8. Serum protein binding characteristics of cyproterone acetate, gestodene, levonorgestrel and norethisterone in rat, rabbit, dog, monkey and man.
    Li QG, Hümpel M.
    J Steroid Biochem; 1990 Feb 01; 35(2):319-26. PubMed ID: 2137890
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
    Kuhnz W, al-Yacoub G, Fuhrmeister A.
    Contraception; 1992 Nov 01; 46(5):455-69. PubMed ID: 1458892
    [Abstract] [Full Text] [Related]

  • 10. Plasma protein binding of norethisterone.
    Odlind V, Victor A, Johansson ED.
    Contraception; 1982 May 01; 25(5):457-62. PubMed ID: 7201915
    [Abstract] [Full Text] [Related]

  • 11. Hormonal and nonhormonal factors affecting sex hormone-binding globulin levels in blood.
    Thijssen JH.
    Ann N Y Acad Sci; 1988 May 01; 538():280-6. PubMed ID: 3056190
    [Abstract] [Full Text] [Related]

  • 12. Release of 19-nor-testosterone type of contraceptive steroids through different drug delivery systems into serum and breast milk of lactating women.
    Toddywalla VS, Mehta S, Virkar KD, Saxena BN.
    Contraception; 1980 Mar 01; 21(3):217-23. PubMed ID: 7389350
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan 01; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 15. Binding of the gestagens norethisterone and levonorgestrel in blood of various species.
    Jenkins N, Fotherby K.
    J Steroid Biochem; 1981 Oct 01; 14(10):1055-62. PubMed ID: 6795390
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH, Poulsen HK, Teisner B, Thorsen P, Hau J, Westergaard JG.
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep 01; 51(1):63-71. PubMed ID: 7506680
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.